RSS Feeds
Search

Press releases

Press releases

Displaying 1..10 of 11 - per page Next page
Order by
Patents were recently granted in 12 new countries for SULIDIN® LPS® (Topical Nimesulide Gel). Licensees are sought in these and other territories worldwide. More
Zambon and APR have recently signed a Strategic Alliance and License Agreement for the further development and marketing of innovative patented consumer oriented products in patch form. More
Questcor Pharmaceuticals has signed an agreement with Beacon Pharmaceuticals of Tunbridge Wells, Kent, UK, for the exclusive marketing and distribution of H.P. Acthar(R) Gel in the United Kingdom. More
Zambon and APR Applied Pharma Research S.A. have signed an international license agreement for the further development of innovative patented products in matrix patch form More
Rapid In-vitro Percutaneous Penetration Profile of Sulidin® 1% Nimesulide LPS topical gel to be presented at the 8'th International Conference on Percutaneous Penetration. More
STOWIC's IP and processes have been acquired by United Pharmaceuticals of Jordan. More
MARKETREADY(TM): a comprehensive, step-by-step process to help meet regulatory standards in pre-approval inspections. More
Scil Biomedicals - Innovative protein-based pharmaceutical products and medical devices More
Weston Medical Group plc - Preliminary results for the year ended 31 December 2001 More
The Performance of the LDI Aerosolization Technology for the Delivery of Antibodies More
Displaying 1..10 of 11 - per page Next page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us